Clark Estates Inc. NY Decreases Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Clark Estates Inc. NY cut its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 10.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 282,740 shares of the company's stock after selling 34,260 shares during the quarter. Pediatrix Medical Group comprises approximately 0.7% of Clark Estates Inc. NY's portfolio, making the stock its 23rd largest holding. Clark Estates Inc. NY owned about 0.33% of Pediatrix Medical Group worth $3,710,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of MD. Quest Partners LLC boosted its holdings in shares of Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after acquiring an additional 622 shares in the last quarter. Everence Capital Management Inc. boosted its holdings in shares of Pediatrix Medical Group by 7.5% in the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company's stock valued at $182,000 after acquiring an additional 960 shares in the last quarter. Parkside Financial Bank & Trust boosted its holdings in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after acquiring an additional 1,040 shares in the last quarter. Quarry LP boosted its holdings in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after acquiring an additional 1,662 shares in the last quarter. Finally, Atria Investments Inc boosted its holdings in shares of Pediatrix Medical Group by 9.0% in the third quarter. Atria Investments Inc now owns 27,124 shares of the company's stock valued at $314,000 after acquiring an additional 2,238 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Pediatrix Medical Group Trading Up 0.9 %

Shares of NYSE:MD traded up $0.13 during trading on Friday, reaching $14.63. The stock had a trading volume of 661,375 shares, compared to its average volume of 817,815. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. The business has a fifty day moving average price of $14.05 and a 200-day moving average price of $13.27. The stock has a market cap of $1.26 billion, a P/E ratio of -12.19, a PEG ratio of 1.74 and a beta of 1.49.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The firm had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. As a group, analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. UBS Group boosted their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a report on Friday, February 21st. Macquarie started coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They set an "outperform" rating and a $18.00 price objective on the stock. Truist Financial lifted their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research report on Friday, February 21st. Mizuho lifted their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a "neutral" rating in a research report on Tuesday, November 19th. Finally, StockNews.com raised shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.